Stanley, A J <br/><br/>
Renal carcinoma cell lines inhibit natural killer activity via the CD94 receptor molecule.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Jul 2001 
 - 260-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0340-7004 
<br/><br/><label>Standard No.: </label>10.1007/s002620100194  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--immunology<br/>Antigens, CD--immunology<br/>Carcinoma, Renal Cell--immunology<br/>Cells, Cultured<br/>Cytotoxicity Tests, Immunologic<br/>Cytotoxicity, Immunologic<br/>Humans<br/>Interleukin-15--pharmacology<br/>K562 Cells<br/>Kidney Neoplasms--immunology<br/>Killer Cells, Natural--drug effects<br/>Lectins, C-Type<br/>Membrane Glycoproteins--immunology<br/>NK Cell Lectin-Like Receptor Subfamily D<br/>Tumor Cells, Cultured<br/>Tumor Escape